Who owns Elicio Therapeutics Inc Com?

Tip: Access positions for across all investors

Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Elicio Therapeutics stock

Who bought or sold Elicio Therapeutics Inc Com this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 175k $1.5M 24% Dec 2023
 View chart
CM Management 50k $417k -23% Dec 2023
 View chart
Citadel Advisors 14k $117k -14% Dec 2023
 View chart
Meyer Handelman 14k $106k 0% Mar 2024
 View chart
Steward Partners Investment Advisory 1.6k $13k 0% Dec 2023
 View chart
Bank of America Corporation 1.1k $9.6k -32% Dec 2023
 View chart
Citigroup 374.00 $3.1k 0% Dec 2023
 View chart
Northwest Capital Management 350.00 $2.7k 0% Mar 2024
 View chart
Royal Bank of Canada 78.00 $999.999000 37% Dec 2023
 View chart
Wells Fargo & Company 43.00 $358.998400 95% Dec 2023
 View chart
UBS Group 16.00 $133.000000 0% Dec 2023
 View chart

Who sold out of Elicio Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Nantahala Capital Management Sep 2023 30k $254k
Millennium Management Sep 2023 20k $172k
CWM Dec 2023 100.00 $1.0k